Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas K Oliver

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
JCO Precision Oncology|April 3, 2026
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer TreatmentVivek Subbiah, Thomas K Oliver, Jim Palma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2017
Reply to M.E.H.M. Van HoefNasser Hanna, Sarah Temin, Thomas K Oliver, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 12, 2011
Inventory of Cancer Guidelines: a tool to advance the guideline enterprise and improve the uptake of evidenceMelissa C Brouwers, Ellen Rawski, Karen Spithoff, et al.
Journal of Oncology Practice|January 23, 2019
ASCO Standards for Safe Handling of Hazardous DrugsPaul Celano, Erin B Kennedy, Thomas K Oliver, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 29, 2007
Health care use and risk of ovarian cancer: is there a link?Michael Fung-Kee-Fung, Melissa Brouwers, Thomas K Oliver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2022
Reply to X. Luo et alVeda N Giri, Thomas K Oliver, R Bryan Rumble, et al.
British Journal of Cancer|December 16, 2024
Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic reviewAlessandro Villa, Bryan J Schneider, Christina Lacchetti, et al.
JCO Oncology Practice|February 20, 2025
Oral Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors: Call to ActionAlessandro Villa, Bryan J Schneider, Christina Lacchetti, et al.
Health Information and Libraries Journal|February 7, 2008
Standardization of search methods for guideline development: an international survey of evidence-based guideline development groupsRikie Deurenberg, Joan Vlayen, Sylvie Guillo, et al.
Gynecologic Oncology|June 30, 2009
Follow-up for women after treatment for cervical cancer: a systematic reviewLaurie Elit, Anthony W Fyles, Michaela C Devries, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
JCO Precision Oncology|April 3, 2026
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer TreatmentVivek Subbiah, Thomas K Oliver, Jim Palma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2017
Reply to M.E.H.M. Van HoefNasser Hanna, Sarah Temin, Thomas K Oliver, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 12, 2011
Inventory of Cancer Guidelines: a tool to advance the guideline enterprise and improve the uptake of evidenceMelissa C Brouwers, Ellen Rawski, Karen Spithoff, et al.
Journal of Oncology Practice|January 23, 2019
ASCO Standards for Safe Handling of Hazardous DrugsPaul Celano, Erin B Kennedy, Thomas K Oliver, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 29, 2007
Health care use and risk of ovarian cancer: is there a link?Michael Fung-Kee-Fung, Melissa Brouwers, Thomas K Oliver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2022
Reply to X. Luo et alVeda N Giri, Thomas K Oliver, R Bryan Rumble, et al.
British Journal of Cancer|December 16, 2024
Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic reviewAlessandro Villa, Bryan J Schneider, Christina Lacchetti, et al.
JCO Oncology Practice|February 20, 2025
Oral Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors: Call to ActionAlessandro Villa, Bryan J Schneider, Christina Lacchetti, et al.
Health Information and Libraries Journal|February 7, 2008
Standardization of search methods for guideline development: an international survey of evidence-based guideline development groupsRikie Deurenberg, Joan Vlayen, Sylvie Guillo, et al.
Gynecologic Oncology|June 30, 2009
Follow-up for women after treatment for cervical cancer: a systematic reviewLaurie Elit, Anthony W Fyles, Michaela C Devries, et al.
Pageof 4